annual cash & cash equivalents:
$229.94M+$156.68M(+213.88%)Summary
- As of today (September 18, 2025), MD annual cash & cash equivalents is $229.94 million, with the most recent change of +$156.68 million (+213.88%) on December 31, 2024.
- During the last 3 years, MD annual cash & cash equivalents has fallen by -$157.45 million (-40.64%).
- MD annual cash & cash equivalents is now -79.54% below its all-time high of $1.12 billion, reached on December 31, 2020.
Performance
MD Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$348.33M+$129.15M(+58.93%)Summary
- As of today (September 18, 2025), MD quarterly cash & cash equivalents is $348.33 million, with the most recent change of +$129.15 million (+58.93%) on June 30, 2025.
- Over the past year, MD quarterly cash & cash equivalents has increased by +$215.13 million (+161.51%).
- MD quarterly cash & cash equivalents is now -71.65% below its all-time high of $1.23 billion, reached on December 31, 2020.
Performance
MD quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MD Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +213.9% | +161.5% |
| 3 y3 years | -40.6% | +224.1% |
| 5 y5 years | +113.2% | +56.4% |
MD Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.6% | +2240.6% | -0.1% | +248.1% |
| 5 y | 5-year | -79.5% | +2240.6% | -71.7% | +260.0% |
| alltime | all time | -79.5% | >+9999.0% | -71.7% | >+9999.0% |
MD Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $348.33M(+58.9%) |
| Mar 2025 | - | $219.18M(-37.1%) |
| Dec 2024 | $229.94M(+213.9%) | $348.51M(+58.1%) |
| Sep 2024 | - | $220.45M(+65.5%) |
| Jun 2024 | - | $133.20M(+15.4%) |
| Mar 2024 | - | $115.47M(-35.0%) |
| Dec 2023 | $73.26M(+645.7%) | $177.74M(+42.5%) |
| Sep 2023 | - | $124.72M(+19.5%) |
| Jun 2023 | - | $104.34M(+1.5%) |
| Mar 2023 | - | $102.83M(-0.2%) |
| Dec 2022 | $9.82M(-97.5%) | $103.06M(+3.0%) |
| Sep 2022 | - | $100.06M(-6.9%) |
| Jun 2022 | - | $107.47M(+11.1%) |
| Mar 2022 | - | $96.75M(-80.1%) |
| Dec 2021 | $387.39M(-65.5%) | $487.11M(+6.7%) |
| Sep 2021 | - | $456.42M(+4.0%) |
| Jun 2021 | - | $438.92M(+18.5%) |
| Mar 2021 | - | $370.44M(-69.9%) |
| Dec 2020 | $1.12B(+941.8%) | $1.23B(+226.7%) |
| Sep 2020 | - | $376.09M(+68.8%) |
| Jun 2020 | - | $222.79M(-43.9%) |
| Mar 2020 | - | $397.20M(+117.8%) |
| Dec 2019 | $107.87M(+323.2%) | $182.38M(+70.0%) |
| Sep 2019 | - | $107.26M(-12.9%) |
| Jun 2019 | - | $123.08M(-7.3%) |
| Mar 2019 | - | $132.70M(+96.8%) |
| Dec 2018 | $25.49M(-57.7%) | $67.41M(-1.5%) |
| Sep 2018 | - | $68.43M(+2.2%) |
| Jun 2018 | - | $66.96M(+29.3%) |
| Mar 2018 | - | $51.78M(-26.5%) |
| Dec 2017 | $60.20M(+8.1%) | $70.49M(+18.7%) |
| Sep 2017 | - | $59.38M(+15.1%) |
| Jun 2017 | - | $51.58M(-2.6%) |
| Mar 2017 | - | $52.98M(-20.9%) |
| Dec 2016 | $55.70M(+8.0%) | $66.98M(+5.8%) |
| Sep 2016 | - | $63.29M(+1.3%) |
| Jun 2016 | - | $62.48M(-2.8%) |
| Mar 2016 | - | $64.28M(+6.4%) |
| Dec 2015 | $51.57M(+7.6%) | $60.42M(-12.3%) |
| Sep 2015 | - | $68.94M(-2.1%) |
| Jun 2015 | - | $70.43M(+23.6%) |
| Mar 2015 | - | $56.99M(+5.6%) |
| Dec 2014 | $47.93M(+53.9%) | $53.96M(-31.8%) |
| Sep 2014 | - | $79.10M(+212.9%) |
| Jun 2014 | - | $25.28M(-8.1%) |
| Mar 2014 | - | $27.50M(-26.9%) |
| Dec 2013 | $31.14M(+46.3%) | $37.59M(+77.6%) |
| Sep 2013 | - | $21.16M(+4.9%) |
| Jun 2013 | - | $20.17M(-49.5%) |
| Mar 2013 | - | $39.96M(+43.4%) |
| Dec 2012 | $21.28M(+14.4%) | $27.86M(-61.2%) |
| Sep 2012 | - | $71.89M(+364.9%) |
| Jun 2012 | - | $15.46M(-41.3%) |
| Mar 2012 | - | $26.33M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $18.60M(-29.2%) | - |
| Jun 2011 | - | $34.94M(+17.6%) |
| Mar 2011 | - | $29.71M(-60.7%) |
| Dec 2010 | $26.25M(-1.0%) | - |
| Sep 2010 | - | $75.61M(+103.7%) |
| Jun 2010 | - | $37.11M(+32.4%) |
| Dec 2009 | $26.50M(+84.7%) | - |
| Sep 2009 | - | $28.02M(-10.2%) |
| Jun 2009 | - | $31.19M(-11.2%) |
| Dec 2008 | $14.35M(-86.1%) | $35.11M(-71.0%) |
| Dec 2007 | $102.84M(+47.8%) | $120.89M(+36.1%) |
| Mar 2007 | - | $88.82M(-34.3%) |
| Dec 2006 | $69.59M(+521.8%) | $135.25M(+227.5%) |
| Jun 2006 | - | $41.29M(+185.5%) |
| Mar 2006 | - | $14.46M(-34.6%) |
| Dec 2005 | $11.19M(+59.6%) | $22.11M(+32.6%) |
| Sep 2005 | - | $16.67M(-2.0%) |
| Jun 2005 | - | $17.02M(+0.3%) |
| Dec 2004 | $7.01M(-74.9%) | $16.97M(-30.2%) |
| Mar 2004 | - | $24.31M(-12.8%) |
| Dec 2003 | $27.90M(-61.9%) | $27.90M(+168.0%) |
| Sep 2003 | - | $10.41M(-9.9%) |
| Jun 2003 | - | $11.55M(-15.2%) |
| Mar 2003 | - | $13.63M(-81.4%) |
| Dec 2002 | $73.19M(+165.6%) | $73.19M(+76.8%) |
| Sep 2002 | - | $41.40M(-36.0%) |
| Jun 2002 | - | $64.73M(+76.9%) |
| Mar 2002 | - | $36.60M(+32.8%) |
| Dec 2001 | $27.56M(+796.2%) | $27.56M(+679.3%) |
| Sep 2001 | - | $3.54M(-20.4%) |
| Jun 2001 | - | $4.44M(+152.8%) |
| Mar 2001 | - | $1.76M(-42.9%) |
| Dec 2000 | $3.08M(+272.7%) | $3.08M(+62.1%) |
| Sep 2000 | - | $1.90M(+58.5%) |
| Jun 2000 | - | $1.20M(+11.0%) |
| Mar 2000 | - | $1.08M(+30.7%) |
| Dec 1999 | $825.00K(+17.9%) | $825.00K(+86.7%) |
| Sep 1999 | - | $442.00K(-24.8%) |
| Jun 1999 | - | $588.00K(+0.7%) |
| Mar 1999 | - | $584.00K(-4.1%) |
| Dec 1998 | $700.00K(-96.2%) | - |
| Sep 1998 | - | $609.00K(-65.3%) |
| Jun 1998 | - | $1.75M(-40.5%) |
| Mar 1998 | - | $2.95M(-84.2%) |
| Dec 1997 | $18.60M(+1.1%) | $18.60M(+64.6%) |
| Sep 1997 | - | $11.30M(-58.8%) |
| Jun 1997 | - | $27.40M(+22.9%) |
| Mar 1997 | - | $22.30M(+21.2%) |
| Dec 1996 | $18.40M(-0.5%) | $18.40M(-51.6%) |
| Sep 1996 | - | $38.00M(+276.2%) |
| Jun 1996 | - | $10.10M(+42.3%) |
| Mar 1996 | - | $7.10M(-61.6%) |
| Dec 1995 | $18.50M(+150.0%) | $18.50M(-58.3%) |
| Sep 1995 | - | $44.40M(+500.0%) |
| Dec 1994 | $7.40M | $7.40M |
FAQ
- What is Pediatrix Medical Group, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pediatrix Medical Group, Inc.?
- What is Pediatrix Medical Group, Inc. annual cash & cash equivalents year-on-year change?
- What is Pediatrix Medical Group, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Pediatrix Medical Group, Inc.?
- What is Pediatrix Medical Group, Inc. quarterly cash & cash equivalents year-on-year change?
What is Pediatrix Medical Group, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of MD is $229.94M
What is the all time high annual cash & cash equivalents for Pediatrix Medical Group, Inc.?
Pediatrix Medical Group, Inc. all-time high annual cash & cash equivalents is $1.12B
What is Pediatrix Medical Group, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, MD annual cash & cash equivalents has changed by +$156.68M (+213.88%)
What is Pediatrix Medical Group, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MD is $348.33M
What is the all time high quarterly cash & cash equivalents for Pediatrix Medical Group, Inc.?
Pediatrix Medical Group, Inc. all-time high quarterly cash & cash equivalents is $1.23B
What is Pediatrix Medical Group, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, MD quarterly cash & cash equivalents has changed by +$215.13M (+161.51%)